Influenza Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Influenza Tests Market Report Overview
The influenza tests market size was $502.6 million in 2023. The market is expected to grow at a CAGR of more than 12% during 2023-2033. Influenza tests are diagnostic tests used to detect the presence of the influenza virus in a patient’s respiratory system. The choice of influenza test depends on a variety of factors, including the severity of the patient’s illness, the timing of the test, and the availability of testing facilities.
Influenza Tests Market Outlook, 2023-2033 ($ Million)
Buy the Full Report for More Insights into the Influenza Tests Market Forecast
The Influenza Tests market research report includes a detailed analysis of the market behavior, which will help identify quantitative market trends in the In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on the influenza tests market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing your in-licensing and out-licensing strategies.
Market Size (2023) | $502.6 million |
CAGR (2023-2033) | >12% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Segments | · Influenza Antigen Tests
· Influenza Lowplex Nucleic Acid Amplification Tests (NAATs) · Influenza Multiplex NAATs |
Key Regions | · North America
· Europe · Asia Pacific · South America · Middle East and Africa |
Leading Companies | · Abbott Laboratories
· Cepheid Inc · Quidel Corp · Roche Diagnostics International Ltd · DiaSorin Molecular LLC + Luminex Corp |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Influenza Tests Market Dynamics
Epidemic influenza causes public health burden each season. The influenza attack rate is the highest in children, while complications including hospitalization and death occur most frequently in elderly individuals. Influenza testing is done through three primary PCR tests. Although NAATs hold a significant market share and will remain the gold standard of testing due to their established and widespread use, POC Antigen and POC NAAT tests are gaining traction. Multiplex NAATs will record increased use with the approach of successive flu seasons, and physician and patient preference will likely be given to such respiratory panels.
Influenza Tests Market Segments
The key segments in the influenza tests market are Influenza Antigen Tests, Influenza Lowplex Nucleic Acid Amplification Tests (NAATs), and Influenza Multiplex NAATs. Influenza Multiplex NAATs led the influenza tests market in 2023. Multiplex Nucleic Acid Amplification Tests (NAATs) are used to screen different respiratory pathogens’ DNA in the patient specimen. The test targets multiple nucleic acid sequences to amplify and detect more than one infection in a single reaction tube.
Influenza Tests Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment Insights into the Influenza Tests Market
Influenza Tests Market Segmentation by Regions
The key regions in the influenza tests market are North America, Europe, Asia Pacific, South America, and the Middle East and Africa. In 2023, North America dominated the influenza tests market. During the forecast period, the influenza tests market is expected to grow in Canada and Mexico and decline in the US. An increase in the number of incident cases and the number of suspected and confirmatory cases opting for influenza tests is driving the influenza tests market growth in Canada.
Influenza Tests Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Influenza Tests Market
Influenza Tests Market - Competitive Landscape
A few of the leading companies in the influenza tests market are:
- Abbott Laboratories
- Cepheid Inc
- Quidel Corp
- Roche Diagnostics International Ltd
- DiaSorin Molecular LLC + Luminex Corp
Abbott Laboratories dominated the market in 2023.
Influenza Tests Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company Insights into the Influenza Tests Market
Segments Covered in the Report
Influenza Tests Segments Outlook (Value, $ Million, 2015-2033)
- Influenza Antigen Tests
- Influenza Lowplex Nucleic Acid Amplification Tests (NAATs)
- Influenza Multiplex NAATs
Influenza Tests Regional Outlook (Value, $ Million, 2015-2033)
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Key Inclusions
Currently marketed Influenza Tests and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Influenza Tests market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Influenza Tests market.
- Competitive dynamics insights and trends provided for the Influenza Tests market.
Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Danaher Corp, Quidelortho Corp, F. Hoffmann-La Roche Ltd, DiaSorin SpA, Becton Dickinson and Co, Qiagen NV, Thermo Fisher Scientific Inc, bioMerieux SA, Sekisui Diagnostics LLC, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This report provides:
- Insightful review of the key industry trends.
- Annualized total Influenza Tests market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Influenza Tests market.
- Competitive dynamics insights and trends provided for the Influenza Tests market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Reasons to Buy
- Understand the impact of COVID-19 on the Influenza Tests market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Influenza Tests market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Influenza Tests market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Influenza Tests market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Danaher Corp
Quidelortho Corp
bioMerieux SA
Sekisui Diagnostics LLC
F. Hoffmann-La Roche Ltd
DiaSorin SpA
Becton Dickinson and Co
Qiagen NV
Thermo Fisher Scientific Inc
Others
Frequently asked questions
-
What was the influenza tests market size in 2023?
The influenza tests market size was $502.6 million in 2023.
-
What will the influenza tests market growth rate be during the forecast period?
The influenza tests market is expected to grow at a CAGR of more than 12% during 2023-2033.
-
Which region dominated the influenza tests market in 2023?
North America dominated the overall influenza tests market in 2023.
-
Which segment led the influenza tests market in 2023?
Influenza Multiplex NAATs led the influenza tests market in 2023.
-
Which are the leading companies in the influenza tests market?
A few of the leading companies in the influenza tests market are Abbott Laboratories, Cepheid Inc, Quidel Corp, Roche Diagnostics International Ltd, and DiaSorin Molecular LLC + Luminex Corp, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.